Prism Pharmaceuticals
Latest round
- Series B
Last raised
- Sep 2006
Total raised
- $30M
Investors
- 2
About Prism Pharmaceuticals
Prism Pharmaceuticals Inc.Prism Pharmaceuticals Inc. was founded in 2003 and is headquartered in King of Prussia, US. The company specializes in developing software solutions aimed at improving operational efficiencies. In a notable development, the company was acquired by Ew Healthcare Partners, though the financial details of the deal remain undisclosed. The current CEO is Boris Bloh, who has experience in leading pharmaceutical ventures.The company specializes in a diverse range of innovative solutions aimed at enhancing operational efficiency for its clients. Its core offerings include advanced software platforms designed for data analytics, customer relationship management, and supply chain optimization. These products are tailored to meet the specific needs of industries such as healthcare, finance, and logistics, helping organizations streamline their processes, improve decision-making, and ultimately drive profitability. The end users of these solutions often include corporate teams, operational managers, and IT departments, who leverage the software to solve challenges related to data management and resource allocation.The revenue model of the company is structured around a subscription-based framework, allowing clients to access its suite of products and services on a recurring basis. Clients typically engage in annual contracts that provide them with access to software updates, customer support, and additional features as they become available. Transactions are primarily B2B, with organizations investing in the company’s software solutions to enhance their operational capabilities. Flagship products in the portfolio contribute significantly to the revenue through tiered pricing plans that cater to different business sizes and needs. For example, larger enterprises may opt for comprehensive packages that include additional functionalities, while small to medium-sized businesses might select more streamlined versions of the software at competitive pricing.Prism Pharmaceuticals Inc. The company is targeting expansion into the Asia-Pacific region by the end of 2024, aiming to establish a stronger foothold in rapidly growing economies. The recent acquisition by Ew Healthcare Partners is expected to support these initiatives and integrate additional resources to bolster development and market outreach.
Who invested in Prism Pharmaceuticals
2 investors across 1 round
See all investors in Prism Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Sep 15, 2006
Amount
$30M
Investors
Questions about Prism Pharmaceuticals
Who invested in Prism Pharmaceuticals?
Prism Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prism Pharmaceuticals raised?
Prism Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Prism Pharmaceuticals last raise money?
Prism Pharmaceuticals's most recent round on record is a Series B, in Sep 2006.
What does Prism Pharmaceuticals do?
Prism Pharmaceuticals is a pharmaceuticals company.
Where is Prism Pharmaceuticals headquartered?
Prism Pharmaceuticals is headquartered in King of Prussia, US.
Which VCs invest in companies like Prism Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Prism Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Prism Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.